Prescribing Patterns of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Patients With Type 2 Diabetes at Cardiology, Endocrinology, and Primary Care Visits

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies

Erik von Elm, Douglas G. Altman, Matthias Egger et al. · The Lancet · 2007 · 18.7K citations · Full text

Public Health, Public Health Practice, Epidemiologic Methods +10

KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease

Kidney International · 2020 · 1.4K citations · Full text

Medicine, Internal Medicine, Nephrology +16

2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines

Salim S. Virani, L. Kristin Newby, Suzanne V. Arnold et al. · Circulation · 2023 · 1.4K citations · Full text

Medicine, Cardiology, Internal Medicine +8

Association of Race/Ethnicity, Gender, and Socioeconomic Status With Sodium-Glucose Cotransporter 2 Inhibitor Use Among Patients With Diabetes in the US

Lauren A. Eberly, Lin Yang, Nwamaka D. Eneanya et al. · JAMA Network Open · 2021 · 339 citations · Full text

Medicine, Cardiology, Pharmacology +17

National Trends in Use of Sodium‐Glucose Cotransporter‐2 Inhibitors and Glucagon‐like Peptide‐1 Receptor Agonists by Cardiologists and Other Specialties, 2015 to 2020

Rishav Adhikari, Kunal Jha, Zeina Dardari et al. · Journal of the American Heart Association · 2022 · 158 citations · Full text

Medicine, Cardiology, Pharmacology +17